N/A Completed N=27 Other

Functionality of the Pulse Oximeter and Accelerometer Portions of a Novel Wearable Device

Hypoxic Events

Source: ClinicalTrials.gov NCT05197790 ↗

Enrolled (actual)

Serious AEs

0.0%

Results posted

Mar 2026

Primary outcomePrimary: Mean Absolute Error of Dove Device Compared to FDA Approved SpO2 Sensor — 0.45 percentage points

Summary

The purpose of this study is to asses the function of an oxygen sensor and the movement sensor in a novel device prototype.

Outcome Measures

Outcome	Result	p-value
PRIMARY Mean Absolute Error of Dove Device Compared to FDA Approved SpO2 Sensor	0.45	—
SECONDARY Questionnaire About Comfort of Device	4.5	—

Eligibility Criteria

Inclusion Criteria

Males and Females
21 years of age or older
Suspected to suffer from hypoxic events
Able to provide informed consent

Exclusion Criteria

Pregnant

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT05197790). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.